Excessive daytime sleepiness and its risk factors in incident Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 2, 2013, Pages 233-234

  Breen, David P ^a   Williams Gray, Caroline H ^a   Mason, Sarah L ^a   Foltynie, Tom ^b   Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; COHORT ANALYSIS; DAYTIME SOMNOLENCE; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SLEEPINESS; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SURVIVAL;

EID: 84872688223     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304097     Document Type: Letter

References (6)

1. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9:185-200.
2. Homann CN, Wenzel K, Suppan K, et al. Sleep attacks in patients taking dopamine agonists. BMJ 2002;324:1483-7.
3. Foltynie T, Brayne CE, Robbins TW, et al. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-60.
4. Boddy F, Rowan EN, Lett D, et al. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2007;22:529-35.
5. Gjerstad MD, Alves G, Wentzel-Larsen T, et al. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006;67:853-8.
6. Selikhova M, Williams DR, Kempster PA, et al. A clinico-pathological study of subtypes in Parkinson's disease. Brain 2009;132:2947-57.